RTW.L
RTW Venture Fund Limited [RTW.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RTW.L Stock Summary
Top 10 Correlated ETFs
RTW.L
Top 10 Correlated Stocks
RTW.L
In the News
RTW.L Financial details
Company Rating
-
Market Cap
508.89M
Income
96.92M
Revenue
3.36M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
-8.21
Forward P/E
-
PEG
0.22
P/S
-0.08
P/B
0.93
P/C
-
P/FCF
0.28
Quick Ratio
5.32
Current Ratio
1.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.45
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
16.79%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-4.07%
SMA50
-12.59%
SMA100
-20.81%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-11%
ROC
-0.1%
Gross Margin
100%
Oper. Margin
106%
Profit Margin
108%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.037-1.9
52W High
+18%
52W Low
+18%
RSI
46.87
Rel Volume
0.16
Avg Volume
914.87K
Volume
145.08K
Perf Week
2.61%
Perf Month
-6.35%
Perf Quarter
-23.38%
Perf Half Y
-23.38%
-
-
-
-
Beta
0.603
-
-
Volatility
0.02%, 0.05%
Prev Close
0%
Price
1.18
Change
0%
Company Profile
- Volume Average 914.87K
- Market Capitalization 508.89M
- CEO Ms. Krisha McCune
- Headquarters New York,NY,US
- IPO Date 2022-11-10
-
Website
https://www.rtwfunds.com/venture-fund 
RTW Venture Fund Limited specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
